Steris reports Q1 EPS $2.00, consensus $1.87

Reports Q2 revenue $1.28B, consensus $1.21B.”We are pleased to start the year with strong performance,” said Dan Carestio, President and Chief Executive Officer of STERIS. “Our first quarter results benefited from continued improvement in procedure volumes and supply chain challenges easing. In addition to those factors, our ability to reduce lead times for Healthcare capital equipment drove our outperformance in the quarter.”